Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.

This paper reviews the major factors that are closely involved in peptide and protein degradation during the preparation of biodegradable nano- and microparticles. The various means usually employed for overcoming these obstacles are described, in order to bring to the fore the strategies for protein stabilization. Both processing and formulation parameters can be modified and are distinctly considered from a strategic point of view. We describe how partial or full protein stability retention within the carriers and during drug release might be achieved by individual or combined optimized strategies. Additionally, problems commonly encountered during protein quantification, stability determination and release are briefly reviewed. Artefacts that might occur during sampling and analytical procedures and which might hinder critical interpretation of results are discussed.

[1]  Wenlei Jiang,et al.  Stabilization and Controlled Release of Bovine Serum Albumin Encapsulated in Poly(D, L-lactide) and Poly(ethylene glycol) Microsphere Blends , 2001, Pharmaceutical Research.

[2]  R. Mehta,et al.  Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption , 1996 .

[3]  S. Charm,et al.  Shear Degradation of Fibrinogen in the Circulation , 1970, Science.

[4]  Wim E. Hennink,et al.  Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles , 2000, Pharmaceutical Research.

[5]  A. Klibanov,et al.  FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[6]  T. Park,et al.  Microencapsulation of dissociable human growth hormone aggregates within poly(D,L-lactic-co-glycolic acid) microparticles for sustained release. , 2001, International journal of pharmaceutics.

[7]  T. Park,et al.  Stabilization of recombinant interferon-α by pegylation for encapsulation in PLGA microspheres , 2003 .

[8]  G. Siber,et al.  Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. , 1997, Vaccine.

[9]  X. Wu,et al.  A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic acid) microspheres using agarose hydrogel , 1998 .

[10]  A. Göpferich,et al.  The effect of poly(ethylene glycol)-poly(D,L-lactic acid) diblock copolymers on peptide acylation. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[11]  E. Topp,et al.  Solid-state chemical stability of proteins and peptides. , 1999, Journal of pharmaceutical sciences.

[12]  J. Gillard,et al.  Protein-loaded poly(epsilon-caprolactone) microparticles III. Entrapment of superoxide dismutase by the (water-in-oil)-in water solvent evaporation method , 1999 .

[13]  Tae Gwan Park,et al.  Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres , 1995 .

[14]  S J Prestrelski,et al.  Precipitation of proteins in supercritical carbon dioxide. , 1996, Journal of pharmaceutical sciences.

[15]  B. Gander,et al.  Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. , 1995, Journal of microencapsulation.

[16]  T. Park,et al.  Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. , 2001, Journal of pharmaceutical sciences.

[17]  A K Panda,et al.  Stabilization of dichloromethane-induced protein denaturation during microencapsulation. , 1998, Pharmaceutical development and technology.

[18]  A. Coombes,et al.  The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Kai Griebenow,et al.  Protein Spray-Freeze Drying. Effect of Atomization Conditions on Particle Size and Stability , 2000, Pharmaceutical Research.

[20]  W Wang,et al.  Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.

[21]  N. Peppas,et al.  Preparation of stable insulin-loaded nanospheres of poly(ethylene glycol) macromers and N-isopropyl acrylamide. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[22]  M. Wirth,et al.  Stabilisation and determination of the biological activity of L-asparaginase in poly(D,L-lactide-co-glycolide) nanospheres. , 2003, International journal of pharmaceutics.

[23]  J L Cleland,et al.  Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Gerhard Winter,et al.  Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients , 1997 .

[25]  H. Sah Protein behavior at the water/methylene chloride interface. , 1999, Journal of pharmaceutical sciences.

[26]  T. Park,et al.  A new preparation method for protein loaded poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[27]  S. Charm,et al.  Shear inactivation of heparin. , 1975, Biorheology.

[28]  K. Griebenow,et al.  Reduction of structural perturbations in bovine serum albumin by non‐aqueous microencapsulation , 2001, The Journal of pharmacy and pharmacology.

[29]  R. Ghaderi,et al.  Biological Activity of Lysozyme After Entrapment in Poly (d,l-lactide-co-glycolide)-Microspheres , 1997, Pharmaceutical Research.

[30]  R. Mehta,et al.  Adsorption of peptides to poly(D,L-lactide-co-glycolide): 1. Effect of physical factors on the adsorption , 1996 .

[31]  C Vigneron,et al.  Preparation and characterization of protein C-loaded PLA nanoparticles. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[32]  B. Gander,et al.  Enhanced Immunogenicity of Microencapsulated Tetanus Toxoid with Stabilizing Agents , 1998, Pharmaceutical Research.

[33]  J. Cleland,et al.  The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres , 1997, Pharmaceutical Research.

[34]  E. Hundt,et al.  Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice , 2001, Pharmaceutical Research.

[35]  A. Glomme,et al.  Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. , 2005, Journal of pharmaceutical sciences.

[36]  G. C. Davis Protein stability: impact upon protein pharmaceuticals. , 1993, Biologicals : journal of the International Association of Biological Standardization.

[37]  Smadar Cohen,et al.  Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy , 1997 .

[38]  G. De Rosa,et al.  Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[39]  T. Park,et al.  Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. , 1998, Journal of microencapsulation.

[40]  P. Debenedetti,et al.  Secondary structure characterization of microparticulate insulin powders. , 1994, Journal of pharmaceutical sciences.

[41]  K. Griebenow,et al.  Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[42]  K. Griebenow,et al.  Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[43]  T. Park,et al.  Pegylation enhances protein stability during encapsulation in PLGA microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[44]  B. Gander,et al.  Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  M. Alonso,et al.  Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[46]  R. Gupta,et al.  Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen. , 1996, Journal of pharmaceutical sciences.

[47]  M. Yeh,et al.  The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol , 2000, Journal of microencapsulation.

[48]  Robert Langer,et al.  Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres , 1993, Pharmaceutical Research.

[49]  S. Singer The Properties of Proteins in Nonaqueous Solvents , 1963 .

[50]  M Morlock,et al.  Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[51]  M. Alonso,et al.  Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[52]  T. Uchida,et al.  Microencapsulation of Hepatitis B Core Antigen for Vaccine Preparation , 1998, Pharmaceutical Research.

[53]  Steven P Schwendeman,et al.  Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. , 2002, Critical reviews in therapeutic drug carrier systems.

[54]  K. Griebenow,et al.  Encapsulation of bovine serum albumin in poly(lactide‐co‐glycolide) microspheres by the solid‐in‐oil‐in‐water technique , 2001, The Journal of pharmacy and pharmacology.

[55]  R. Heeren,et al.  Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[56]  J. Cleland,et al.  Stable Formulations of Recombinant Human Growth Hormone and Interferon-γ for Microencapsulation in Biodegradable Mircospheres , 1996, Pharmaceutical Research.

[57]  T. Park,et al.  Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. , 1995, PDA journal of pharmaceutical science and technology.

[58]  J. Brange,et al.  Chemical stability of insulin. 3. Influence of excipients, formulation, and pH. , 1992, Acta pharmaceutica Nordica.

[59]  J. Carpenter,et al.  Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. , 1999, Journal of pharmaceutical sciences.

[60]  E. Allémann,et al.  Sonication Parameters for the Preparation of Biodegradable Nanocapsulesof Controlled Size by the Double Emulsion Method , 2003, Pharmaceutical development and technology.

[61]  M. Alonso,et al.  Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. , 1999, International journal of pharmaceutics.

[62]  W. Tiyaboonchai,et al.  Insulin containing polyethylenimine-dextran sulfate nanoparticles. , 2003, International journal of pharmaceutics.

[63]  J. O'Shea,et al.  The effect of ultrasonic irradiation on proteins. , 1973, Australian journal of biological sciences.

[64]  P. G. Shao,et al.  Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. , 1999, Pharmaceutical development and technology.

[65]  T. Park,et al.  Stability and release of bovine serum albumin encapsulated within poly(d,l-lactide-co-glycolide) microparticles , 1996 .

[66]  C L Stevenson,et al.  Characterization of protein and peptide stability and solubility in non-aqueous solvents. , 2000, Current pharmaceutical biotechnology.

[67]  R. Langer,et al.  Improved immunogenicity of a core-coated tetanus toxoid delivery system. , 1999, Vaccine.

[68]  Y. Yamaguchi,et al.  Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[69]  J. Benoit,et al.  NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[70]  Y. Youn,et al.  Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[71]  M. L. La Rotonda,et al.  Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[72]  L. Meinel,et al.  Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[73]  Jian Ding,et al.  PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers , 2001 .

[74]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.

[75]  J L Cleland,et al.  Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. , 2001, Journal of pharmaceutical sciences.

[76]  J. Benoit,et al.  Why Does PEG 400 Co-Encapsulation Improve NGF Stability and Release from PLGA Biodegradable Microspheres? , 1999, Pharmaceutical Research.

[77]  M. Morlock,et al.  Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[78]  E. Leo,et al.  Protein immobilization in crosslinked alginate microparticles , 2002, Journal of microencapsulation.

[79]  X. Li,et al.  Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[80]  Huub Schellekens,et al.  Immunogenicity of rDNA-derived pharmaceuticals. , 2002, Trends in pharmacological sciences.

[81]  A. Klibanov,et al.  On protein solubility in organic solvent. , 1994, Biotechnology and bioengineering.

[82]  V. Préat,et al.  Preparation and characterization of alginate microspheres containing a model antigen , 1998 .

[83]  Y. Kawashima,et al.  In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. , 1994, Journal of pharmaceutical sciences.

[84]  K. Suslick,et al.  The sonochemical hot spot , 1987 .

[85]  R. Brown,et al.  The inactivation of enzymes by ultrasonic cavitation at 20 kHz , 1973 .

[86]  Jagdish Singh,et al.  Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[87]  H. Sah A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres. , 1997, Journal of pharmaceutical sciences.

[88]  Jeffrey L. Cleland,et al.  Technical and regulatory hurdles in delivery aspects of macromolecular drugs , 1996 .

[89]  Robert Langer,et al.  Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres , 1991, Pharmaceutical Research.

[90]  S. Schwendeman,et al.  Influence of basic salts on stability and release of proteins in injectable poly(lactide-co-glycolide) delivery devices , 1999 .

[91]  R. Gupta,et al.  Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. , 1994, Vaccine.

[92]  S. Sharif,et al.  A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles , 1995 .

[93]  S. W. Kim,et al.  In Situ Study of Insulin Aggregation Induced by Water-Organic Solvent Interface , 2001, Pharmaceutical Research.

[94]  Jagdish Singh,et al.  Lysozyme Stability in Primary Emulsion for PLGA Microsphere Preparation: Effect of Recovery Methods and Stabilizing Excipients , 2002, Pharmaceutical Research.

[95]  Y. Yamagata,et al.  Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[96]  S. Charm,et al.  Enzyme inactivation with shearing. , 1970, Biotechnology and bioengineering.

[97]  D. Quintanar-Guerrero,et al.  Applications of the Ion-Pair Concept to Hydrophilic Substances with Special Emphasis on Peptides , 1997, Pharmaceutical Research.

[98]  María J. Alonso,et al.  Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres , 1997 .

[99]  Ge Jiang,et al.  Preparation and Characterization of a Composite PLGA and Poly(Acryloyl Hydroxyethyl Starch) Microsphere System for Protein Delivery , 2001, Pharmaceutical Research.

[100]  B. Gander,et al.  Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[101]  R. Mehta,et al.  Adsorption of Salmon Calcitonin to PLGA Microspheres , 1995, Pharmaceutical Research.

[102]  B. C. Thanoo,et al.  Preparation, Characterization, and In Vitro Evaluation of 1- and 4-Month Controlled Release Orntide PLA and PLGA Microspheres , 2000, Pharmaceutical development and technology.

[103]  S. Schwendeman,et al.  Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres. , 2001, Journal of pharmaceutical sciences.

[104]  J L Cleland,et al.  Emerging protein delivery methods. , 2001, Current opinion in biotechnology.

[105]  W J Lin,et al.  Characterization of protein-loaded poly(epsilon-caprolactone) microparticles based on a factorial design. , 2001, Journal of microencapsulation.

[106]  C. Sturesson,et al.  Incorporation of protein in PLG-microspheres with retention of bioactivity. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[107]  K. Griebenow,et al.  Stabilization of alpha-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[108]  L. Jorgensen,et al.  Secondary structure alterations in insulin and growth hormone water-in-oil emulsions. , 2003, International journal of pharmaceutics.

[109]  Alexander M. Klibanov,et al.  On Protein Denaturation in Aqueous−Organic Mixtures but Not in Pure Organic Solvents , 1996 .

[110]  Y. Chiu,et al.  FDA perspective on peptide formulation and stability issues. , 1998, Journal of pharmaceutical sciences.

[111]  K. Griebenow,et al.  Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method. , 2002, International journal of pharmaceutics.

[112]  M. Alonso,et al.  Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[113]  D. Hochstrasser,et al.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for quantitation and molecular stability assessment of insulin entrapped within PLGA nanoparticles. , 2005, Journal of pharmaceutical sciences.

[114]  N. Elvassore,et al.  Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. , 2001, Journal of pharmaceutical sciences.

[115]  W. Hennink,et al.  The effect of a water/organic solvent interface on the structural stability of lysozyme. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[116]  B. Gander,et al.  Improving Stability and Release Kinetics of Microencapsulated Tetanus Toxoid by Co-Encapsulation of Additives , 1998, Pharmaceutical Research.

[117]  C Vigneron,et al.  Protein C-loaded monomethoxypoly (ethylene oxide)-poly(lactic acid) nanoparticles. , 2001, International journal of pharmaceutics.